Pearls in the management of macular holes

Seminars in Ophthalmology

Volumn 13, Issue 1, 1998, Pages 10-19

  Nao I, Nobuhisa ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; TISSUE ADHESIVE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; ASPIRATION; CATARACT; CHOROID HEMORRHAGE; CLINICAL TRIAL; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; HYPERTROPHY; LENS IMPLANT; MAJOR CLINICAL STUDY; MALE; PHACOEMULSIFICATION; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA TEAR; SCLERA BUCKLING PROCEDURE; SERUM; STAGING; SURGICAL TECHNIQUE; VISUAL ACUITY; VITRECTOMY;

EID: 0031898474     PISSN: 08820538     EISSN: None     Source Type: Journal    
DOI: 10.3109/08820539809066078     Document Type: Article

References (32)

1. Johnson R, Gass JDM. Idiopathic macular holes. Observations, stages of formation, and implications for surgical intervention. Ophthalmology. 1988;95:917-924.
2. Gass JDM. Idiopathic senile macular hole. Its early stages and pathogenesis. Arch Ophthalmol. 1988;106:629-639.
3. Kelly NE, Wendel RT. Vitreous surgery for idiopathic macular holes. Results of a pilot study. Arch Ophthalmol. 1991;109:654-659.
4. Orellana J, Lieberman RM. Stage III macular hole surgery. Br J Ophthalmol. 1993;77:555-558.
5. Glaser BM, Michels RG, Kuppermann BD, et al. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study. Ophthalmology. 1992;99:1162-1172.
6. Lansing MB, Glaser BM, Liss H, Hanham A, et al. The effect of pars plana vitrectomy and transforming growth factorbeta 2 without epiretinal membrane peeling on full-thickness macular holes. Ophthalmology. 1993;100:868-871.
7. Wendel RT, Patel AC, Kelly NE, et al. Vitreous surgery for macular holes. Ophthalmology. 1993;100:1671-1676.
8. Ryan EH Jr., Gilbert HD. Results of surgical treatment of recent-onset full-thickness idiopathic macular holes. Arch Ophthalmol. 1994;112:1545-1553.
9. Christmas NJ, Skolik SA, Howard MA, et al. Treatment of retinal breaks with autologous serum in an experimental model. Ophthalmology. 1995;102:263-271.
10. Liggett PE, Skolik DS, Horio B, et al. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study. Ophthalmology. 1995;102:1071-1076.
11. Monin C, Barale PO, Harrabi S, et al. Surgical treatment by vitrectomy and autologous serum of 36 idiopathic macular holes. J Fr Ophtalmol. 1996;19:341-348.
12. Mori K, Yoneya S, Abe T. Vitrectomy with autoserum for idiopathic macular hole. Nippon Ganka Gakkai Zasshi. 1996;100: 458-463.
13. Wells JA, Gregor ZJ. Surgical treatment of full-thickness macular holes using autologous serum. Eye. 1996;10:593-599.
14. Kozy DW, Maberley AL. Closure of persistent macular holes with human recombinant transforming growth factor-beta 2. Can J Ophthalmol. 1996;31:179-182.
15. Rubin JS, Glaser BM, Thompson JT, et al. Vitrectomy, fluid-gas exchange and transforming growth factor-beta2 for the treatment of traumatic macular holes. Ophthalmology. 1995;102: 1840-1845.
16. Smiddy WE, Glaser BM, Thompson JT, et al. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Preliminary anatomic results of a multicenter prospective randomized study. Retina. 1993;13:296-301.
17. Tilanus MA, Deutman AF. Full-thickness macular holes treated with vitrectomy and tissue glue. Int Ophthalmol. 1994;18: 355-358.
18. Cohen SM. Intraocular Adjuvants, Macular Hole Surgery, and Endophthalmitis. Vitreous Society Online Journal. http://www.vitreoussociety.org/journal/origin/cohen/machol17. htm 1996.
19. Yooh HS, Brooks HL Jr., Capone A Jr., et al. Ultrastructural features of tissue removed during idiopathic macular hole surgery. Am J Ophthalmol. 1996;122:67-75.
20. Gass JDM. Reappraisal of biomicroscopic classification of stages of development of a macular hole. Am J Ophthalmol. 1995;119:752-759.
21. Thompson JT, Glaser BM, Sjaarda RN, et al. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes. Am J Ophthalmol. 1995;119:48-54.
22. Park SS, Marcus DM, Duker JS, et al. Posterior segment complications after vitrectomy for macular hole. Ophthalmology. 1995;102:775-781.
23. Miller JH Jr., Googe JM Jr., Hoskins JC. Combined macular hole and cataract surgery. Am J Ophthalmol. 1997;123: 705-707.
24. Tsujikawa M, Ohji M, Fujikado T, et al. Differentiating full thickness macular holes from impending macular holes and macular pseudoholes. Br J Ophthalmol. 1997;81:117-122.
25. Del Priore LV, Kaplan HJ, Silverman M, et al. Surgical removal of the retinal pigment epithelium in the domestic pig. Invest Ophthalmol Vis Sci. 1994;35(suppl):1334.
26. Lopez PF, Hovanesian H, Spee C, et al. RPE wound healing in vivo: A new model. Invest Ophthalmol Vis Sci. 1994;35(suppl):1335.
27. Del Priore LV, Kaplan HJ, Bonham RD. Laser photocoagulation and fluid-gas exchange for recurrent macular hole. Retina. 1994;14:381-382.
28. Morinaga T, Ogino N, Iwaki M. Surgical treatment of macular hole-the effect of the removal of retinal pigment epithelium in hard cases. Folia Ophthalmol Jpn. 1995;46:1294-1296.
29. Kondo M, Morinaga T, Ogino N. Reopening of macular hole after initial surgical cure in three eyes. Jpn Rev Clin Ophthalmol. 1995;89:993-996.
30. Rosa RH Jr., Glaser BM, de la Cruz Z, et al. Clinicopathologic correlation of an untreated macular hole and a macular hole treated by vitrectomy, transforming growth factor-beta 2, and gas tamponade. Am J Ophthalmol. 1996;122:853-863.
31. Fekrat S, Wendel RT, de la Cruz Z, et al. Clinicopathologic correlation of an epiretinal membrane associated with a recurrent macular hole. Retina. 1995;15:53-57.
32. Madreperla SA, Geiger GL, Funata M, et al. Clinicopathologic correlation of a macular hole treated by cortical vitreous peeling and gas tamponade. Ophthalmology. 1994;101:682686.